[The impairment of glycogen metabolism in adipose tissue by 6-aminonicotinamide as influenced by the inhibition of phosphofructokinase].
D000244:Adenosine Diphosphate; D000273:Adipose Tissue / Q000201:enzymology / Q000378:metabolism*; D000588:Amines; D000818:Animals; D002245:Carbon Dioxide / Q000096:biosynthesis; D002247:Carbon Isotopes; D004336:Drug Antagonism; D004822:Epididymis; D005636:Fructosephosphates; D005947:Glucose / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism*; D006008:Glycogen Storage Disease / Q000201:enzymology; D007328:Insulin / Q000494:pharmacology; D008297:Male; D009132:Muscles / Q000201:enzymology; D009536:Niacinamide / Q000494:pharmacology*; D010732:Phosphofructokinase-1 / Q000037:antagonists & inhibitors*; D011817:Rabbits; D011874:Radiometry; D051381:Rats
D000588:Amines; D002247:Carbon Isotopes; D005636:Fructosephosphates; D007328:Insulin; D002245:Carbon Dioxide; D009536:Niacinamide; D000244:Adenosine Diphosphate; D006003:Glycogen; D010732:Phosphofructokinase-1; D005947:Glucose
Uber die Hemmung der Phosphofurctokinase im Rahmen der Störungen des Glykogenstoffwechsels im Fettgewebe durch 6-Aminonicotinamid.